Is loss of CD44 and SOX2 expression correlated with a poor prognosis in esophageal adenocarcinoma patients?
Loss of CD44 expression and loss of SOX2 expression are prognostic factors of poor survival in EAC patients. This suggests a role of these proteins in EAC that requires further investigation.
Promoting the recognition and management of AD in pregnant women may be of interest for the prevention of postnatal depression.